This figure, which translates to nearly 1 in 12 adults, highlights the significant public health challenge the state faces regarding substance use and addiction<sup class="citation-ref" data-citation-hash="cite-substanceuse" data-source="Nj" data-year="2023" data-url="https://www.nj.gov/humanservices/dmhas/publications/statistical/Substance%20Abuse%20Overview/2023/Statewide.pdf" data-ama="Substance Use Overview 2023 Statewide. Nj. Published 2023. Accessed January 2026. https://www.nj.gov/humanservices/dmhas/publications/statistical/Substance%20Abuse%20Overview/2023/Statewide.pdf"></sup>.
Key Takeaways on Substance Use in New Jersey
- New Jersey's adult SUD prevalence of 8.5% is higher than the national average of 7.4%.8.5%
- Young adults aged 18-25 are disproportionately affected, with a prevalence rate of 12.5%.12.5%
- A significant treatment gap persists, with 65% of individuals with SUD in New Jersey not receiving any form of treatment.65%
- The state saw a notable decline in overdose deaths, from 3,054 in 2022 to 2,564 in 2023, suggesting progress in harm reduction efforts.2,564 deaths
- Urban counties in New Jersey report higher SUD prevalence (9.1%) compared to rural areas (6.7%).9.1% vs 6.7%
- New Jersey faces a significant shortage of mental health providers, with an estimated ratio of one provider for every 1,500 residents.
Understanding Substance Use Disorder in New Jersey
Substance Use Disorder (SUD) represents a significant public health issue across the United States and within New Jersey. Nationally, approximately 16.8% of the population aged 12 or older, or 48.4 million people, meet the criteria for an SUD[8]. In New Jersey, the challenge is compounded by factors like economic instability and stigma surrounding behavioral health[7]. This page provides a data-driven overview of SUD prevalence, treatment access, and demographic trends within the state, drawing from authoritative sources to offer a clear picture of the current landscape.
Substance Use Disorder (SUD)
Source: Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5)
SUD Prevalence and Co-Occurring Conditions
Understanding the prevalence of SUD is the first step in addressing its impact. In New Jersey, the rate of SUD is slightly higher than the national average, with data showing 8.2% of adults in the state meeting criteria compared to 7.1% nationally in recent years[9]. Substance use is often intertwined with other mental health challenges. A substantial portion of the state's population grapples with these issues, which can complicate diagnosis and treatment. Furthermore, the state's suicide rate, while lower than the national average at 12 per 100,000 residents, remains a serious concern connected to both SUD and mental illness[10].
Demographic Disparities in Substance Use
Substance Use Disorder does not affect all populations equally. Significant disparities exist across age, race, and geography within New Jersey. Young adults are particularly vulnerable, with prevalence rates nearly double that of older adults[4]. Opioid use disorder specifically affects about 3.2% of this young adult demographic[7]. Geographic and racial disparities are also evident, with urban areas and certain racial groups experiencing higher rates. While rural areas show lower overall prevalence, they often face unique barriers to care, such as transportation issues and fewer qualified providers[13].
The Treatment Gap: Access to Care in New Jersey
Despite having a higher density of treatment providers than the national average, a significant portion of New Jersey residents with SUD do not receive care[1]. Less than half of individuals with a diagnosed SUD—around 38-45% depending on the survey—report receiving any treatment in the past year[7]. Systemic barriers, including stigma, provider shortages in certain areas, and financial constraints, contribute to this gap[4]. Even among the 85% of adults with insurance coverage for mental health, many face challenges securing timely appointments[3].
This treatment gap is slightly better than the national figure of 70% but still represents a major public health failure.
Substance Abuse and Mental Health Services Administration (2023)Highlights the critical role of public insurance in providing care, though systemic issues can undermine its effectiveness<sup class="citation-ref" data-citation-hash="cite-pdfsubstance" data-source="Nj" data-year="2022" data-url="https://www.nj.gov/humanservices/dmhas/publications/statistical/Substance%20Abuse%20Overview/2022/Statewide.pdf" data-ama="[PDF] Substance Use Overview 2022 Statewide - NJ.gov. Nj. Published 2022. Accessed January 2026. https://www.nj.gov/humanservices/dmhas/publications/statistical/Substance%20Abuse%20Overview/2022/Statewide.pdf"></sup>.
Nj (2022)This rate is higher than the national average of 18 per 100,000, yet access issues persist due to uneven distribution and other barriers.
Substance Abuse and Mental Health Services Administration (2023)Trends in Substance Use Over Time
Data from recent years indicate a concerning upward trend in the prevalence of Substance Use Disorder among adults in New Jersey. This gradual increase underscores the persistent nature of the SUD crisis and the need for evolving strategies in prevention and treatment. For example, the SUD diagnosis rate among the state's Medicaid beneficiaries rose by 15% between 2017 and 2022 alone[7]. Visualizing this trend helps to contextualize the current statistics and highlights the urgency of public health responses.
Economic Impact and Treatment Outcomes
The economic burden of untreated SUD is substantial, affecting healthcare costs, productivity, and public resources. In response, New Jersey has increased funding for behavioral health services by 20% since 2020 and ranks in the top 10 states for per capita mental health spending[11]. However, this funding is often unevenly allocated, leaving some communities underserved[11]. When treatment is accessed, outcomes can be positive, with nearly 60% of patients reporting significant improvements in quality of life[7]. The 40% who do not show marked improvement highlight ongoing gaps in treatment modalities and long-term support[16].
Frequently Asked Questions
Sources & References
All statistics and claims on this page are supported by peer-reviewed research and official government data sources.